10 Best “Strong Buy” Stocks — LCC CVI MHO and more

Portfolio Grader gives these picks top marks

   
10 Best “Strong Buy” Stocks — LCC CVI MHO and more

This week, these ten stocks, all currently earning A’s (“strong buy”) on Portfolio Grader, have the best year-to-date performance. Since the beginning of the year, the Nasdaq 13.7%, the Dow rose 6%, and the S&P has risen 11.7%.

Since the first of the year, the price of US Airways (NYSE:LCC) has swelled 162.7%. US Airways Group provides air transportation for passengers and cargo. The stock currently has a trailing PE Ratio of 4.20. For more information, get Portfolio Grader’s complete analysis of LCC stock.

Since January 1, CVR Energy (NYSE:CVI) has jumped 163.1%. CVR Energy engages in refining and marketing transportation fuels in the United States. For more information, get Portfolio Grader’s complete analysis of CVI stock.

Since January 1, the price of M/I Homes (NYSE:MHO) has grown 167.7%. M/I Homes builds single-family homes that are marketed and sold under the M/I Homes and Showcase Homes trade names. For more information, get Portfolio Grader’s complete analysis of MHO stock.

Since January 1, Conn’s Inc. (NASDAQ:CONN) has shot up 173%. Conn’s is a specialty retailer of home appliances and consumer electronics. For more information, get Portfolio Grader’s complete analysis of CONN stock.

PulteGroup (NYSE:PHM) has risen 188.9% since the first of the year. PulteGroup sells and constructs homes, and purchases, develops, and sells residential land and develops active adult communities. For more information, get Portfolio Grader’s complete analysis of PHM stock.

Shares of Lumber Liquidators (NYSE:LL) have risen 191% since January 1. Lumber Liquidators retails hardwood flooring in the United States. For more information, get Portfolio Grader’s complete analysis of LL stock.

The price of Regeneron Pharmaceuticals (NASDAQ:REGN) is up 213.2% since the first of the year. Regeneron Pharmaceuticals researches, develops and commercializes therapeutics to treat human disorders and conditions. For more information, get Portfolio Grader’s complete analysis of REGN stock.

Shares of Santarus (NASDAQ:SNTS) have leapt 239.4% since January 1. Santarus, Inc. was incorporated in California in December 1996 and reincorporated in Delaware in July 2002. It is a specialty pharmaceutical company focused on acquiring, developing and commercializing proprietary products that address the needs of patients treated by gastroenterologists and other targeted physicians. For more information, get Portfolio Grader’s complete analysis of SNTS stock.

Since January 1, 3D Systems (NYSE:DDD) has climbed 260.4%. 3D Systems engages in the design, development, manufacture, marketing, and servicing of 3D printers and related products, print materials, and services. For more information, get Portfolio Grader’s complete analysis of DDD stock.

The price of Pharmacyclics (NASDAQ:PCYC) has seen a 306.8% boost since the first of the year. Pharmacyclics is a pharmaceutical company developing products to improve upon current therapeutic approaches to cancer, atherosclerosis, and retinal disease. For more information, get Portfolio Grader’s complete analysis of PCYC stock.

Louis Navellier’s proprietary Portfolio Grader stock ranking system assesses roughly 5,000 companies every week based on a number of fundamental and quantitative measures. Stocks are given a letter grade based on their results — with A being “strong buy,” and F being “strong sell.” Explore the tool here.


Article printed from InvestorPlace Media, http://investorplace.com/2012/12/10-best-strong-buy-stocks-lcc-cvi-mho-and-more-lcc-cvi-mho-conn-phm-ll-regn-snts-ddd-pcyc-2/.

©2014 InvestorPlace Media, LLC

Comments are currently unavailable. Please check back soon.